<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: DISEASE TREATMENT: splicing interference</title>
<meta name="Author" content="Robert J. Bradbury (bradbury@aeiveos.com)">
<meta name="Subject" content="DISEASE TREATMENT: splicing interference">
<meta name="Date" content="2003-01-09">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>DISEASE TREATMENT: splicing interference</h1>
<!-- received="Thu Jan  9 13:48:54 2003" -->
<!-- isoreceived="20030109204854" -->
<!-- sent="Thu, 9 Jan 2003 12:48:52 -0800 (PST)" -->
<!-- isosent="20030109204852" -->
<!-- name="Robert J. Bradbury" -->
<!-- email="bradbury@aeiveos.com" -->
<!-- subject="DISEASE TREATMENT: splicing interference" -->
<!-- id="Pine.LNX.4.44.0301091246140.15710-100000@server.aeiveos.com" -->
<!-- charset="US-ASCII" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Robert J. Bradbury (<a href="mailto:bradbury@aeiveos.com?Subject=Re:%20DISEASE%20TREATMENT:%20splicing%20interference"><em>bradbury@aeiveos.com</em></a>)<br>
<strong>Date:</strong> Thu Jan 09 2003 - 13:48:52 MST
</p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="0424.html">Rafal Smigrodzki: "RE: Whose business is it, anyway?"</a>
<li><strong>Previous message:</strong> <a href="0422.html">Robert J. Bradbury: "Adult Stem Cells: critical insight"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#423">[ date ]</a>
<a href="index.html#423">[ thread ]</a>
<a href="subject.html#423">[ subject ]</a>
<a href="author.html#423">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
A novel method of treating various diseases, including some
<br>
cancers, has been demonstrated using antisense oligonucleotides
<br>
to interfere with gene splicing variants that are responsible
<br>
for promoting the disease.
<br>
<p>See:
<br>
UNC Studies Target Molecular Defects Implicated In Cancer,
<br>
Genetic Diseases
<br>
<a href="http://www.sciencedaily.com/releases/2003/01/030109071146.htm">http://www.sciencedaily.com/releases/2003/01/030109071146.htm</a>
<br>
<p>R.
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="0424.html">Rafal Smigrodzki: "RE: Whose business is it, anyway?"</a>
<li><strong>Previous message:</strong> <a href="0422.html">Robert J. Bradbury: "Adult Stem Cells: critical insight"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#423">[ date ]</a>
<a href="index.html#423">[ thread ]</a>
<a href="subject.html#423">[ subject ]</a>
<a href="author.html#423">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Wed Jan 15 2003 - 17:35:51 MST
</em></small></p>
</body>
</html>
